0001520138-23-000530.txt : 20231206 0001520138-23-000530.hdr.sgml : 20231206 20231206161504 ACCESSION NUMBER: 0001520138-23-000530 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231109 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERMAN RICHARD J CENTRAL INDEX KEY: 0001111620 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39015 FILM NUMBER: 231469763 MAIL ADDRESS: STREET 1: 305 COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVIE INC. CENTRAL INDEX KEY: 0001580149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462510769 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 BUSINESS PHONE: 775-888-3162 MAIL ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 FORMER COMPANY: FORMER CONFORMED NAME: NANOANTIBIOTICS, INC. DATE OF NAME CHANGE: 20130625 4 1 ownership.xml X0508 4 2023-11-09 0 0001580149 BIOVIE INC. BIVI 0001111620 BERMAN RICHARD J C/O BIOVIE INC. 680 W NYE LANE STE 201 CARSON CITY NV 89703 1 0 0 0 0 Common Stock 2023-11-09 4 A 0 51830 0.00 A 69235 D The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting. On August 22, 2023, the reporting person filed a Form 4 which inadvertently reported that, following his exercise of an option and sale of the underlying stock, he directly owned 16,789 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 17,405 shares of common stock. /S/ RICHARD J BERMAN 2023-12-05